FDA recall record

Nationwide Laboratories Phenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count recall — FDA D-0168-2017

CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

Class IIclassification
D-0168-2017official record ID
Dec 7, 2016report date

Recall record at a glance

Official recordD-0168-2017
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmNationwide Laboratories, LLC
Report dateDec 7, 2016
Recall initiation dateOct 28, 2016
Quantity5,786,653 tablets
LocationIselin, NJ, United States

Official product description

Phenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830, NDC 42937-702-10.

Why the product was recalled

CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

Distribution information

Nationwide in USA and Puerto Rico

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.